ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lonotropic Glutamate Receptor Antagonist Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-29C12784
Home | Market Reports | Science| Biological Sciences
Global Lonotropic Glutamate Receptor Antagonist Market Research Report 2023
BUY CHAPTERS

Global Lonotropic Glutamate Receptor Antagonist Market Insights, Forecast to 2030

Code: QYRE-Auto-29C12784
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc
NeurOp Inc
UCB SA
Novartis
Luc Therapeutics Inc
Evotec AG

Lonotropic Glutamate Receptor Antagonist Market

Ionic glutamate receptor antagonists, including: the N-methyl-D-aspartate receptor, the maricin receptor, and the alpha-amino-3-hydroxy-5 methyl-4 isoxazole receptor, which are coupled to ion channels to form receptor channel complexes that mediate fast signalling.
The global Lonotropic Glutamate Receptor Antagonist market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Lonotropic Glutamate Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Lonotropic Glutamate Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Lonotropic Glutamate Receptor Antagonist is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Lonotropic Glutamate Receptor Antagonist include Artemis Neuroscience, VistaGen Therapeutics, Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH and Cerecor Inc., etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Lonotropic Glutamate Receptor Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Lonotropic Glutamate Receptor Antagonist, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lonotropic Glutamate Receptor Antagonist, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lonotropic Glutamate Receptor Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Lonotropic Glutamate Receptor Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Lonotropic Glutamate Receptor Antagonist sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Lonotropic Glutamate Receptor Antagonist Market Report

Report Metric Details
Report Name Lonotropic Glutamate Receptor Antagonist Market
Segment by Type
  • N-Methyl-D-Aspartate Receptors
  • Marine Human Alginate Receptors
  • α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
Segment by Application
  • Hospitals
  • Clinics
  • Research Institutes
  • Others
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH, Cerecor Inc., NeurOp Inc., UCB SA, Novartis AG, Luc Therapeutics Inc., Evotec AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Lonotropic Glutamate Receptor Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Lonotropic Glutamate Receptor Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lonotropic Glutamate Receptor Antagonist sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lonotropic Glutamate Receptor Antagonist Market report?

Ans: The main players in the Lonotropic Glutamate Receptor Antagonist Market are Rottapharm Madaus, Amorsa Therapeutics, Newron Pharmaceuticals, Purdue Biopharma, Relmada Therapeutics, BioCrea GmbH, Cerecor Inc., NeurOp Inc., UCB SA, Novartis AG, Luc Therapeutics Inc., Evotec AG

What are the Application segmentation covered in the Lonotropic Glutamate Receptor Antagonist Market report?

Ans: The Applications covered in the Lonotropic Glutamate Receptor Antagonist Market report are Hospitals, Clinics, Research Institutes, Others

What are the Type segmentation covered in the Lonotropic Glutamate Receptor Antagonist Market report?

Ans: The Types covered in the Lonotropic Glutamate Receptor Antagonist Market report are N-Methyl-D-Aspartate Receptors, Marine Human Alginate Receptors, α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors

Recommended Reports

Receptor Antagonist Markets

Nervous System Drugs

Amino Acid Related

1 Study Coverage
1.1 Lonotropic Glutamate Receptor Antagonist Product Introduction
1.2 Market by Type
1.2.1 Global Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 N-Methyl-D-Aspartate Receptors
1.2.3 Marine Human Alginate Receptors
1.2.4 α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
1.3 Market by Application
1.3.1 Global Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Lonotropic Glutamate Receptor Antagonist Sales Estimates and Forecasts 2019-2030
2.2 Global Lonotropic Glutamate Receptor Antagonist Revenue by Region
2.2.1 Global Lonotropic Glutamate Receptor Antagonist Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Lonotropic Glutamate Receptor Antagonist Revenue by Region (2019-2024)
2.2.3 Global Lonotropic Glutamate Receptor Antagonist Revenue by Region (2025-2030)
2.2.4 Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Region (2019-2030)
2.3 Global Lonotropic Glutamate Receptor Antagonist Sales Estimates and Forecasts 2019-2030
2.4 Global Lonotropic Glutamate Receptor Antagonist Sales by Region
2.4.1 Global Lonotropic Glutamate Receptor Antagonist Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2019-2024)
2.4.3 Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2025-2030)
2.4.4 Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Lonotropic Glutamate Receptor Antagonist Sales by Manufacturers
3.1.1 Global Lonotropic Glutamate Receptor Antagonist Sales by Manufacturers (2019-2024)
3.1.2 Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lonotropic Glutamate Receptor Antagonist in 2023
3.2 Global Lonotropic Glutamate Receptor Antagonist Revenue by Manufacturers
3.2.1 Global Lonotropic Glutamate Receptor Antagonist Revenue by Manufacturers (2019-2024)
3.2.2 Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Lonotropic Glutamate Receptor Antagonist Revenue in 2023
3.3 Global Key Players of Lonotropic Glutamate Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Lonotropic Glutamate Receptor Antagonist Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lonotropic Glutamate Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lonotropic Glutamate Receptor Antagonist, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lonotropic Glutamate Receptor Antagonist, Product Offered and Application
3.8 Global Key Manufacturers of Lonotropic Glutamate Receptor Antagonist, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Lonotropic Glutamate Receptor Antagonist Sales by Type
4.1.1 Global Lonotropic Glutamate Receptor Antagonist Historical Sales by Type (2019-2024)
4.1.2 Global Lonotropic Glutamate Receptor Antagonist Forecasted Sales by Type (2025-2030)
4.1.3 Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
4.2 Global Lonotropic Glutamate Receptor Antagonist Revenue by Type
4.2.1 Global Lonotropic Glutamate Receptor Antagonist Historical Revenue by Type (2019-2024)
4.2.2 Global Lonotropic Glutamate Receptor Antagonist Forecasted Revenue by Type (2025-2030)
4.2.3 Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
4.3 Global Lonotropic Glutamate Receptor Antagonist Price by Type
4.3.1 Global Lonotropic Glutamate Receptor Antagonist Price by Type (2019-2024)
4.3.2 Global Lonotropic Glutamate Receptor Antagonist Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Lonotropic Glutamate Receptor Antagonist Sales by Application
5.1.1 Global Lonotropic Glutamate Receptor Antagonist Historical Sales by Application (2019-2024)
5.1.2 Global Lonotropic Glutamate Receptor Antagonist Forecasted Sales by Application (2025-2030)
5.1.3 Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
5.2 Global Lonotropic Glutamate Receptor Antagonist Revenue by Application
5.2.1 Global Lonotropic Glutamate Receptor Antagonist Historical Revenue by Application (2019-2024)
5.2.2 Global Lonotropic Glutamate Receptor Antagonist Forecasted Revenue by Application (2025-2030)
5.2.3 Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
5.3 Global Lonotropic Glutamate Receptor Antagonist Price by Application
5.3.1 Global Lonotropic Glutamate Receptor Antagonist Price by Application (2019-2024)
5.3.2 Global Lonotropic Glutamate Receptor Antagonist Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Lonotropic Glutamate Receptor Antagonist Market Size by Type
6.1.1 US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2030)
6.1.2 US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2030)
6.2 US & Canada Lonotropic Glutamate Receptor Antagonist Market Size by Application
6.2.1 US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2030)
6.2.2 US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2030)
6.3 US & Canada Lonotropic Glutamate Receptor Antagonist Market Size by Country
6.3.1 US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Country (2019-2030)
6.3.3 US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Lonotropic Glutamate Receptor Antagonist Market Size by Type
7.1.1 Europe Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2030)
7.1.2 Europe Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2030)
7.2 Europe Lonotropic Glutamate Receptor Antagonist Market Size by Application
7.2.1 Europe Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2030)
7.2.2 Europe Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2030)
7.3 Europe Lonotropic Glutamate Receptor Antagonist Market Size by Country
7.3.1 Europe Lonotropic Glutamate Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2019-2030)
7.3.3 Europe Lonotropic Glutamate Receptor Antagonist Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Lonotropic Glutamate Receptor Antagonist Market Size
8.1.1 China Lonotropic Glutamate Receptor Antagonist Sales (2019-2030)
8.1.2 China Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030)
8.2 China Lonotropic Glutamate Receptor Antagonist Market Size by Application
8.2.1 China Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2030)
8.2.2 China Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Lonotropic Glutamate Receptor Antagonist Market Size by Type
9.1.1 Asia Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2030)
9.1.2 Asia Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2030)
9.2 Asia Lonotropic Glutamate Receptor Antagonist Market Size by Application
9.2.1 Asia Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2030)
9.2.2 Asia Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2030)
9.3 Asia Lonotropic Glutamate Receptor Antagonist Sales by Region
9.3.1 Asia Lonotropic Glutamate Receptor Antagonist Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Lonotropic Glutamate Receptor Antagonist Revenue by Region (2019-2030)
9.3.3 Asia Lonotropic Glutamate Receptor Antagonist Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Market Size by Type
10.1.1 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Market Size by Application
10.2.1 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country
10.3.1 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Artemis Neuroscience
11.1.1 Artemis Neuroscience Company Information
11.1.2 Artemis Neuroscience Overview
11.1.3 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Artemis Neuroscience Recent Developments
11.2 VistaGen Therapeutics
11.2.1 VistaGen Therapeutics Company Information
11.2.2 VistaGen Therapeutics Overview
11.2.3 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 VistaGen Therapeutics Recent Developments
11.3 Rottapharm Madaus
11.3.1 Rottapharm Madaus Company Information
11.3.2 Rottapharm Madaus Overview
11.3.3 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Rottapharm Madaus Recent Developments
11.4 Amorsa Therapeutics
11.4.1 Amorsa Therapeutics Company Information
11.4.2 Amorsa Therapeutics Overview
11.4.3 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Amorsa Therapeutics Recent Developments
11.5 Newron Pharmaceuticals
11.5.1 Newron Pharmaceuticals Company Information
11.5.2 Newron Pharmaceuticals Overview
11.5.3 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Newron Pharmaceuticals Recent Developments
11.6 Purdue Biopharma
11.6.1 Purdue Biopharma Company Information
11.6.2 Purdue Biopharma Overview
11.6.3 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Purdue Biopharma Recent Developments
11.7 Relmada Therapeutics
11.7.1 Relmada Therapeutics Company Information
11.7.2 Relmada Therapeutics Overview
11.7.3 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Relmada Therapeutics Recent Developments
11.8 BioCrea GmbH
11.8.1 BioCrea GmbH Company Information
11.8.2 BioCrea GmbH Overview
11.8.3 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 BioCrea GmbH Recent Developments
11.9 Cerecor Inc.
11.9.1 Cerecor Inc. Company Information
11.9.2 Cerecor Inc. Overview
11.9.3 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cerecor Inc. Recent Developments
11.10 NeurOp Inc.
11.10.1 NeurOp Inc. Company Information
11.10.2 NeurOp Inc. Overview
11.10.3 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 NeurOp Inc. Recent Developments
11.11 UCB SA
11.11.1 UCB SA Company Information
11.11.2 UCB SA Overview
11.11.3 UCB SA Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 UCB SA Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 UCB SA Recent Developments
11.12 Novartis AG
11.12.1 Novartis AG Company Information
11.12.2 Novartis AG Overview
11.12.3 Novartis AG Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Novartis AG Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Novartis AG Recent Developments
11.13 Luc Therapeutics Inc.
11.13.1 Luc Therapeutics Inc. Company Information
11.13.2 Luc Therapeutics Inc. Overview
11.13.3 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Luc Therapeutics Inc. Recent Developments
11.14 Evotec AG
11.14.1 Evotec AG Company Information
11.14.2 Evotec AG Overview
11.14.3 Evotec AG Lonotropic Glutamate Receptor Antagonist Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Evotec AG Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Evotec AG Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Lonotropic Glutamate Receptor Antagonist Industry Chain Analysis
12.2 Lonotropic Glutamate Receptor Antagonist Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lonotropic Glutamate Receptor Antagonist Production Mode & Process
12.4 Lonotropic Glutamate Receptor Antagonist Sales and Marketing
12.4.1 Lonotropic Glutamate Receptor Antagonist Sales Channels
12.4.2 Lonotropic Glutamate Receptor Antagonist Distributors
12.5 Lonotropic Glutamate Receptor Antagonist Customers
13 Market Dynamics
13.1 Lonotropic Glutamate Receptor Antagonist Industry Trends
13.2 Lonotropic Glutamate Receptor Antagonist Market Drivers
13.3 Lonotropic Glutamate Receptor Antagonist Market Challenges
13.4 Lonotropic Glutamate Receptor Antagonist Market Restraints
14 Key Findings in The Global Lonotropic Glutamate Receptor Antagonist Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Artemis Neuroscience
VistaGen Therapeutics
Rottapharm Madaus
Amorsa Therapeutics
Newron Pharmaceuticals
Purdue Biopharma
Relmada Therapeutics
BioCrea GmbH
Cerecor Inc
NeurOp Inc
UCB SA
Novartis
Luc Therapeutics Inc
Evotec AG
List of Tables
    Table 1. Global Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of N-Methyl-D-Aspartate Receptors
    Table 3. Major Manufacturers of Marine Human Alginate Receptors
    Table 4. Major Manufacturers of α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors
    Table 5. Global Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Lonotropic Glutamate Receptor Antagonist Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Lonotropic Glutamate Receptor Antagonist Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Lonotropic Glutamate Receptor Antagonist Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Region (2019-2024)
    Table 10. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Region (2025-2030)
    Table 11. Global Lonotropic Glutamate Receptor Antagonist Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2019-2024) & (Units)
    Table 13. Global Lonotropic Glutamate Receptor Antagonist Sales by Region (2025-2030) & (Units)
    Table 14. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Region (2019-2024)
    Table 15. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Region (2025-2030)
    Table 16. Global Lonotropic Glutamate Receptor Antagonist Sales by Manufacturers (2019-2024) & (Units)
    Table 17. Global Lonotropic Glutamate Receptor Antagonist Sales Share by Manufacturers (2019-2024)
    Table 18. Global Lonotropic Glutamate Receptor Antagonist Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Lonotropic Glutamate Receptor Antagonist, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Lonotropic Glutamate Receptor Antagonist Price by Manufacturers 2019-2024 (US$/Unit)
    Table 22. Global Lonotropic Glutamate Receptor Antagonist Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Lonotropic Glutamate Receptor Antagonist by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lonotropic Glutamate Receptor Antagonist as of 2023)
    Table 24. Global Key Manufacturers of Lonotropic Glutamate Receptor Antagonist, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Lonotropic Glutamate Receptor Antagonist, Product Offered and Application
    Table 26. Global Key Manufacturers of Lonotropic Glutamate Receptor Antagonist, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2024) & (Units)
    Table 29. Global Lonotropic Glutamate Receptor Antagonist Sales by Type (2025-2030) & (Units)
    Table 30. Global Lonotropic Glutamate Receptor Antagonist Sales Share by Type (2019-2024)
    Table 31. Global Lonotropic Glutamate Receptor Antagonist Sales Share by Type (2025-2030)
    Table 32. Global Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Lonotropic Glutamate Receptor Antagonist Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Type (2019-2024)
    Table 35. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Type (2025-2030)
    Table 36. Lonotropic Glutamate Receptor Antagonist Price by Type (2019-2024) & (US$/Unit)
    Table 37. Global Lonotropic Glutamate Receptor Antagonist Price Forecast by Type (2025-2030) & (US$/Unit)
    Table 38. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2024) & (Units)
    Table 39. Global Lonotropic Glutamate Receptor Antagonist Sales by Application (2025-2030) & (Units)
    Table 40. Global Lonotropic Glutamate Receptor Antagonist Sales Share by Application (2019-2024)
    Table 41. Global Lonotropic Glutamate Receptor Antagonist Sales Share by Application (2025-2030)
    Table 42. Global Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Lonotropic Glutamate Receptor Antagonist Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Application (2019-2024)
    Table 45. Global Lonotropic Glutamate Receptor Antagonist Revenue Share by Application (2025-2030)
    Table 46. Lonotropic Glutamate Receptor Antagonist Price by Application (2019-2024) & (US$/Unit)
    Table 47. Global Lonotropic Glutamate Receptor Antagonist Price Forecast by Application (2025-2030) & (US$/Unit)
    Table 48. US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2024) & (Units)
    Table 49. US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Type (2025-2030) & (Units)
    Table 50. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2024) & (Units)
    Table 53. US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Application (2025-2030) & (Units)
    Table 54. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Country (2019-2024) & (Units)
    Table 60. US & Canada Lonotropic Glutamate Receptor Antagonist Sales by Country (2025-2030) & (Units)
    Table 61. Europe Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2024) & (Units)
    Table 62. Europe Lonotropic Glutamate Receptor Antagonist Sales by Type (2025-2030) & (Units)
    Table 63. Europe Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Lonotropic Glutamate Receptor Antagonist Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2024) & (Units)
    Table 66. Europe Lonotropic Glutamate Receptor Antagonist Sales by Application (2025-2030) & (Units)
    Table 67. Europe Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Lonotropic Glutamate Receptor Antagonist Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Lonotropic Glutamate Receptor Antagonist Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Lonotropic Glutamate Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Lonotropic Glutamate Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2019-2024) & (Units)
    Table 73. Europe Lonotropic Glutamate Receptor Antagonist Sales by Country (2025-2030) & (Units)
    Table 74. China Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2024) & (Units)
    Table 75. China Lonotropic Glutamate Receptor Antagonist Sales by Type (2025-2030) & (Units)
    Table 76. China Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Lonotropic Glutamate Receptor Antagonist Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2024) & (Units)
    Table 79. China Lonotropic Glutamate Receptor Antagonist Sales by Application (2025-2030) & (Units)
    Table 80. China Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Lonotropic Glutamate Receptor Antagonist Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2024) & (Units)
    Table 83. Asia Lonotropic Glutamate Receptor Antagonist Sales by Type (2025-2030) & (Units)
    Table 84. Asia Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Lonotropic Glutamate Receptor Antagonist Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2024) & (Units)
    Table 87. Asia Lonotropic Glutamate Receptor Antagonist Sales by Application (2025-2030) & (Units)
    Table 88. Asia Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Lonotropic Glutamate Receptor Antagonist Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Lonotropic Glutamate Receptor Antagonist Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Lonotropic Glutamate Receptor Antagonist Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Lonotropic Glutamate Receptor Antagonist Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Lonotropic Glutamate Receptor Antagonist Sales by Region (2019-2024) & (Units)
    Table 94. Asia Lonotropic Glutamate Receptor Antagonist Sales by Region (2025-2030) & (Units)
    Table 95. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Type (2019-2024) & (Units)
    Table 96. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Type (2025-2030) & (Units)
    Table 97. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Application (2019-2024) & (Units)
    Table 100. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Application (2025-2030) & (Units)
    Table 101. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2019-2024) & (Units)
    Table 107. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales by Country (2025-2030) & (Units)
    Table 108. Artemis Neuroscience Company Information
    Table 109. Artemis Neuroscience Description and Major Businesses
    Table 110. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 111. Artemis Neuroscience Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Artemis Neuroscience Recent Developments
    Table 113. VistaGen Therapeutics Company Information
    Table 114. VistaGen Therapeutics Description and Major Businesses
    Table 115. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 116. VistaGen Therapeutics Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. VistaGen Therapeutics Recent Developments
    Table 118. Rottapharm Madaus Company Information
    Table 119. Rottapharm Madaus Description and Major Businesses
    Table 120. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 121. Rottapharm Madaus Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Rottapharm Madaus Recent Developments
    Table 123. Amorsa Therapeutics Company Information
    Table 124. Amorsa Therapeutics Description and Major Businesses
    Table 125. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 126. Amorsa Therapeutics Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Amorsa Therapeutics Recent Developments
    Table 128. Newron Pharmaceuticals Company Information
    Table 129. Newron Pharmaceuticals Description and Major Businesses
    Table 130. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 131. Newron Pharmaceuticals Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Newron Pharmaceuticals Recent Developments
    Table 133. Purdue Biopharma Company Information
    Table 134. Purdue Biopharma Description and Major Businesses
    Table 135. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 136. Purdue Biopharma Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Purdue Biopharma Recent Developments
    Table 138. Relmada Therapeutics Company Information
    Table 139. Relmada Therapeutics Description and Major Businesses
    Table 140. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 141. Relmada Therapeutics Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Relmada Therapeutics Recent Developments
    Table 143. BioCrea GmbH Company Information
    Table 144. BioCrea GmbH Description and Major Businesses
    Table 145. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 146. BioCrea GmbH Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. BioCrea GmbH Recent Developments
    Table 148. Cerecor Inc. Company Information
    Table 149. Cerecor Inc. Description and Major Businesses
    Table 150. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 151. Cerecor Inc. Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Cerecor Inc. Recent Developments
    Table 153. NeurOp Inc. Company Information
    Table 154. NeurOp Inc. Description and Major Businesses
    Table 155. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 156. NeurOp Inc. Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. NeurOp Inc. Recent Developments
    Table 158. UCB SA Company Information
    Table 159. UCB SA Description and Major Businesses
    Table 160. UCB SA Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 161. UCB SA Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. UCB SA Recent Developments
    Table 163. Novartis AG Company Information
    Table 164. Novartis AG Description and Major Businesses
    Table 165. Novartis AG Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 166. Novartis AG Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. Novartis AG Recent Developments
    Table 168. Luc Therapeutics Inc. Company Information
    Table 169. Luc Therapeutics Inc. Description and Major Businesses
    Table 170. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 171. Luc Therapeutics Inc. Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Luc Therapeutics Inc. Recent Developments
    Table 173. Evotec AG Company Information
    Table 174. Evotec AG Description and Major Businesses
    Table 175. Evotec AG Lonotropic Glutamate Receptor Antagonist Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 176. Evotec AG Lonotropic Glutamate Receptor Antagonist Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Evotec AG Recent Developments
    Table 178. Key Raw Materials Lists
    Table 179. Raw Materials Key Suppliers Lists
    Table 180. Lonotropic Glutamate Receptor Antagonist Distributors List
    Table 181. Lonotropic Glutamate Receptor Antagonist Customers List
    Table 182. Lonotropic Glutamate Receptor Antagonist Market Trends
    Table 183. Lonotropic Glutamate Receptor Antagonist Market Drivers
    Table 184. Lonotropic Glutamate Receptor Antagonist Market Challenges
    Table 185. Lonotropic Glutamate Receptor Antagonist Market Restraints
    Table 186. Research Programs/Design for This Report
    Table 187. Key Data Information from Secondary Sources
    Table 188. Key Data Information from Primary Sources
List of Figures
    Figure 1. Lonotropic Glutamate Receptor Antagonist Product Picture
    Figure 2. Global Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Lonotropic Glutamate Receptor Antagonist Market Share by Type in 2023 & 2030
    Figure 4. N-Methyl-D-Aspartate Receptors Product Picture
    Figure 5. Marine Human Alginate Receptors Product Picture
    Figure 6. α-Amino-3 Hydroxy-5 Methyl-4 Isoxazole Receptors Product Picture
    Figure 7. Global Lonotropic Glutamate Receptor Antagonist Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Lonotropic Glutamate Receptor Antagonist Market Share by Application in 2023 & 2030
    Figure 9. Hospitals
    Figure 10. Clinics
    Figure 11. Research Institutes
    Figure 12. Others
    Figure 13. Lonotropic Glutamate Receptor Antagonist Report Years Considered
    Figure 14. Global Lonotropic Glutamate Receptor Antagonist Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Lonotropic Glutamate Receptor Antagonist Revenue 2019-2030 (US$ Million)
    Figure 16. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Region (2019-2030)
    Figure 18. Global Lonotropic Glutamate Receptor Antagonist Sales 2019-2030 ((Units)
    Figure 19. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Lonotropic Glutamate Receptor Antagonist Sales YoY (2019-2030) & (Units)
    Figure 21. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Lonotropic Glutamate Receptor Antagonist Sales YoY (2019-2030) & (Units)
    Figure 23. Europe Lonotropic Glutamate Receptor Antagonist Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Lonotropic Glutamate Receptor Antagonist Sales YoY (2019-2030) & (Units)
    Figure 25. China Lonotropic Glutamate Receptor Antagonist Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Lonotropic Glutamate Receptor Antagonist Sales YoY (2019-2030) & (Units)
    Figure 27. Asia (excluding China) Lonotropic Glutamate Receptor Antagonist Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales YoY (2019-2030) & (Units)
    Figure 29. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Lonotropic Glutamate Receptor Antagonist Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Lonotropic Glutamate Receptor Antagonist in the World: Market Share by Lonotropic Glutamate Receptor Antagonist Revenue in 2023
    Figure 32. Global Lonotropic Glutamate Receptor Antagonist Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
    Figure 34. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
    Figure 35. Global Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
    Figure 36. Global Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Lonotropic Glutamate Receptor Antagonist Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Lonotropic Glutamate Receptor Antagonist Sales Share by Country (2019-2030)
    Figure 43. U.S. Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
    Figure 46. Europe Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
    Figure 48. Europe Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Lonotropic Glutamate Receptor Antagonist Revenue Share by Country (2019-2030)
    Figure 50. Europe Lonotropic Glutamate Receptor Antagonist Sales Share by Country (2019-2030)
    Figure 51. Germany Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 52. France Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 56. China Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
    Figure 57. China Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
    Figure 58. China Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
    Figure 59. China Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
    Figure 61. Asia Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
    Figure 63. Asia Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Lonotropic Glutamate Receptor Antagonist Revenue Share by Region (2019-2030)
    Figure 65. Asia Lonotropic Glutamate Receptor Antagonist Sales Share by Region (2019-2030)
    Figure 66. Japan Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 70. India Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Lonotropic Glutamate Receptor Antagonist Sales Share by Country (2019-2030)
    Figure 77. Brazil Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Lonotropic Glutamate Receptor Antagonist Revenue (2019-2030) & (US$ Million)
    Figure 82. Lonotropic Glutamate Receptor Antagonist Value Chain
    Figure 83. Lonotropic Glutamate Receptor Antagonist Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Glutamate Antagonist Market Research Report 2025
Global NMDA Receptor Antagonist Market Research Report 2025
AMPA Receptors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glutamate Receptor Ionotropic NMDA 2B Market Research Report 2025
Global Metabotropic Glutamate Receptor MRG Market Research Report 2024
Global Neurokinin Receptor Antagonists Market Research Report 2024
Global P2X7 Receptor Antagonists Market Insights Forecast to 2030
Global GnRH Receptor Antagonists Market Research Report 2024
Global Memantine HCL API Market Research Report 2025
Global Neurokinin Receptor Antagonists API Market Research Report 2024
Global γ Aminobutyric Acid Receptor Agonists Market Research Report 2025
Global Sodium Myristoyl Glutamate Market Research Report 2024
Global Sodium Palmitoyl Glutamate Market Research Report 2024
Global Purinergic Receptor Antagonists Market Research Report 2024
Global Ionic Amino Acid Surfactants Market Research Report 2024
Global Metabotropic Glutamate Receptor 1 Market Research Report 2025
Angiotensin Receptor Antagonists Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GABA Receptor Modulators Market Research Report 2025
Global Androgen Receptor AR Antagonist Market Research Report 2024
Global Glutamate Surfactants Market Research Report 2024

RELATED REPORTS

Global Salt Active Nuclease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6W17226
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Parietal Bone Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34V19460
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6C20013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Genome Editing Tool Enzymes Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37K19803
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions